Citation
Differentiated obesity treatment: Pharmacological CRF2 agonism drives fat loss, skeletal muscle hypertrophy and improved glucose metabolism in preclinical obesity. // Molecular Metabolism. – URL: https://www.sciencedirect.com/science/article/pii/S2212877826001523?dgcid=rss_sd_all
Differentiated obesity treatment: Pharmacological CRF2 agonism drives fat loss, skeletal muscle hypertrophy and improved glucose metabolism in preclinical obesity. Molecular Metabolism. https://www.sciencedirect.com/science/article/pii/S2212877826001523?dgcid=rss_sd_all
“Differentiated obesity treatment: Pharmacological CRF2 agonism drives fat loss, skeletal muscle hypertrophy and improved glucose metabolism in preclinical obesity.” Molecular Metabolism.
@article{article58975,
title = {Differentiated obesity treatment: Pharmacological CRF2 agonism drives fat loss, skeletal muscle hypertrophy and improved glucose metabolism in preclinical obesity},
journal = {Molecular Metabolism},
url = {https://www.sciencedirect.com/science/article/pii/S2212877826001523?dgcid=rss_sd_all}
}